Gene expression of fibrinolytic factors urokinase plasminogen activator and plasminogen activator inhibitor-1 in rabbit temporomandibular joint cartilage with disc displacement

Chinese Medical Journal

Volumn 118, Issue 12, 2005, Pages 1000-1006

  Zhan, Jing ^a   Gu, Zhi Yuan ^a   Wu, Li Qun ^b   Zhang, Yin Kai ^a   Hu, Ji An ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Disc displacement; In situ hybridization; Plasminogen activator inhibitor 1; Temporomandibular joint; Urokinase plasminogen activator

Indexed keywords

FIBRINOLYTIC FACTOR; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE MINERALIZATION; BONE REMODELING; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; FIBRINOLYSIS; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RABBIT; SIGNAL TRANSDUCTION; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; UPREGULATION;

ANIMALS; CARTILAGE, ARTICULAR; DISLOCATIONS; FEMALE; MALE; MANDIBULAR CONDYLE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RABBITS; RNA, MESSENGER; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISK; URINARY PLASMINOGEN ACTIVATOR;

EID: 21344433903     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ali AM, Sharawy MM. Histopathological changes in rabbit craniomandibular joint associated with experimentally induced anterior disk displacement (ADD). J Oral Pathol Med 1994;23:364-374.
2. Zhang ZK, Ma XC, Gao S, et al. Studies on contributing factors in temporomandibular disorders. Chin J Dent Res (Chin) 1999;2:7-20.
3. Gu Z, Wu H, Feng J, et al. Adaptive alterations of elastic fibers in the bilaminar zone of rabbit temporomandibular joint following disc displacement. Chin Med J 2002;12:1772-1776.
4. Walter H, Kawashima A, Nebelung W, et al. Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. Pathol Res Pract 1998;194:73-81.
5. Zhang X, Bu X, Zhen H, et al. Expression and significance of urokinase-type plasminogen activator in human gliomas. Chin Med J 2000;9:802-804.
6. Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function and regulation. J Biol Chem 1994;269:15957-15960.
7. Tamura N, Uzuki M, Matsumoto F, et al. Expression of urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR) plays a role in destruction of joint tissue in rapidly destructive coxarthropathy (RDC). Ryumachi 2001;41:851-857.
8. Del Rosso M, Fibbi G, Matucci Cerinic M. The urokinase-type plasminogen activator system and inflammatory joint diseases. Clin Exp Rheumatol 1999; 17:485-498.
9. Zhang Y, Gu Z, Zhan J, et al. Evaluation on the method of persistent inducing anterior disc displacement of temporomandibular joint through orbit. J Pract Stomatol (Chin) 2004;20:418-421.
10. Oberg T, Carlsson GE. Macroscopic and microscopic anatomy of the TMJ. In: Zarb CA, Carlsson GE, eds. Temporomandibular joint: function and dysfunction. Munksgaard: Copenhaden; 1979:101-118.
11. Hilal G, Martel Pelletier J, Pelletier JP, et al. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts. Arthritis Rheum 1999;42:2112-2122.
12. Ronday HK, Smits HH, Van Muijen GN, et al. Difference in expression of the plasminogen activator system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1996;35: 416-423.
13. Yuan GH, Masuko Hongo K, Kato T, et al. Immunologic intervention in the pathogenesis of osteoarthritis. Arthritis Rheum 2003;48:602-611.
14. Ramont L, Pasco S, Hornebeck W, et al. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system. Exp Cell Res 2003; 291:1-10.
15. Sieuwerts AM, Klijn JG, Henzen Logmans SC, et al. Cytokine-regulated urokinase-type-plasminogenactivator-(uPA) production by human breast fibroblasts in vitro. Breast Cancer Res Treat 1999;55:9-20.
16. Siconolfi LB, Seeds NW. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J Neurosci 2001;21:4348-4355.
17. Farmand M, Mommaerts M, Teuscher U. Facial growth after treatment of unilateral temporomandibular joint ankylosis in childhood without growth center transplantation. A serial cephalomorphomtric study. J Cranimoaxillofac Surg 1989;17:260-270.
18. Vaughan DE. Angiotensin and vascular fibrinolytic balance. Am J Hypertens 2002;15(1 Pt 2):S3-S8.
19. Ali AM, Sharawy M. Enlargement of the rabbit mandibular condyle after experimental induction of anterior disc displacement: a histomorphometric study. J Oral Maxillofac Surg 1995;5:544-560.
20. Kikuchi H, Shimada W, Nonaka T, et al. Significance of serine proteinase and matrix metalloproteinase systems in the destruction of human articular cartilage. Clin Exp Pharmacol Physiol 1996;23:885-889.
21. Pelletier JP, Mineau F, Fernandes J, et al. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human CA synovial fibroblasts. Clin Exp Rheumatol 1997;15:393-398.
22. Busso N, Peclat V, So A, et al. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis 1997;56:550-557.
23. Belcher C, Fawthrop F, Bunning R, et al. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis 1996;55:230-236.
24. Baker EA, Leaper DJ. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. Eur J Cancer 2003; 39:981-988.
25. Garbett EA, Reed MW, Stephenson TJ, et al. Proteolysis in human breast cancer. Mol Pathol 2000; 53:99-106.